| Q91638794 | Alleviation of Intestinal Inflammation by Oral Supplementation With 2-Fucosyllactose in Mice |
| Q49696827 | Alterations in the epithelial stem cell compartment could contribute to permanent changes in the mucosa of patients with ulcerative colitis. |
| Q33816839 | An ex vivo method for studying mucus formation, properties, and thickness in human colonic biopsies and mouse small and large intestinal explants. |
| Q34987870 | Antimicrobial peptides and gut microbiota in homeostasis and pathology. |
| Q36792480 | Butyrate-producing Clostridium cluster XIVa species specifically colonize mucins in an in vitro gut model |
| Q92219890 | Calcium-activated chloride channel regulator 1 (CLCA1): More than a regulator of chloride transport and mucus production |
| Q43974142 | Cathelicidin-encoding Lactococcus lactis promotes mucosal repair in murine experimental colitis |
| Q33837769 | Coherent somatic mutation in autoimmune disease |
| Q60048713 | Colonocyte metabolism shapes the gut microbiota |
| Q38026391 | Commensal-innate immune miscommunication in IBD pathogenesis |
| Q41379177 | Core 2 Mucin-Type O-Glycan Is Related to EPEC and EHEC O157:H7 Adherence to Human Colon Carcinoma HT-29 Epithelial Cells |
| Q45034747 | Decreased colonization of fecal Clostridium coccoides/Eubacterium rectale species from ulcerative colitis patients in an in vitro dynamic gut model with mucin environment |
| Q42129549 | Design of a specific colonic mucus marker using a human commensal bacterium cell surface domain |
| Q38681194 | Dietary Supplementation of Fermented Rice Bran Effectively Alleviates Dextran Sodium Sulfate-Induced Colitis in Mice. |
| Q34959929 | Dietary grape seed extract ameliorates symptoms of inflammatory bowel disease in IL10-deficient mice |
| Q34129323 | Discordance between changes in the gut microbiota and pathogenicity in a mouse model of spontaneous colitis. |
| Q27321681 | Epithelial IL-18 Equilibrium Controls Barrier Function in Colitis |
| Q51081156 | Epithelial cell types and their proposed roles in maintaining the mucosal barrier in human chagasic-megacolonic mucosa. |
| Q28732754 | Host genetics and environmental factors regulate ecological succession of the mouse colon tissue-associated microbiota |
| Q35825870 | Importance and regulation of the colonic mucus barrier in a mouse model of colitis |
| Q33901644 | In vivo analysis of mucosal lipids reveals histological disease activity in ulcerative colitis using endoscope-coupled Raman spectroscopy |
| Q90424923 | Increased Epithelial Oxygenation Links Colitis to an Expansion of Tumorigenic Bacteria |
| Q34036608 | Inflammatory bowel disease in pediatric and adolescent patients: a biomolecular and histopathological review |
| Q39439937 | Inflammatory cues modulate the expression of secretory product genes, Golgi sulfotransferases and sulfomucin production in LS174T cells. |
| Q35142966 | Influences of the colonic microbiome on the mucous gel layer in ulcerative colitis |
| Q98462825 | Insufficient dietary choline aggravates disease severity in a mouse model of Citrobacter rodentium-induced colitis |
| Q41450553 | Interactions of Intestinal Bacteria with Components of the Intestinal Mucus |
| Q41677213 | Intestinal Host-Microbe Interactions under Physiological and Pathological Conditions |
| Q26781239 | Intestinal Microbiota and the Innate Immune System - A Crosstalk in Crohn's Disease Pathogenesis |
| Q39388017 | Intestinal barrier integrity and inflammatory bowel disease: Stem cell-based approaches to regenerate the barrier. |
| Q39404775 | MIP-3α expression in macrophages is NOD dependent |
| Q28572873 | Maternal deprivation alters epithelial secretory cell lineages in rat duodenum: role of CRF-related peptides |
| Q28555167 | Metformin Improves Ileal Epithelial Barrier Function in Interleukin-10 Deficient Mice |
| Q38953543 | Molecular pathways driving disease-specific alterations of intestinal epithelial cells |
| Q55450202 | N-Acetyl-glucosamine influences the biofilm formation of Escherichia coli. |
| Q92668932 | Nanoparticulate Drug Delivery Systems Targeting Inflammation for Treatment of Inflammatory Bowel Disease |
| Q35619589 | Physiological relevance of food grade microcapsules: Impact of milk protein based microcapsules on inflammation in mouse models for inflammatory bowel diseases. |
| Q26796416 | Saccharomyces boulardii CNCM I-745 supports regeneration of the intestinal microbiota after diarrheic dysbiosis - a review |
| Q40800103 | Saturated and Unsaturated Fatty Acids Differently Modulate Colonic Goblet Cells In Vitro and in Rat Pups |
| Q37213038 | Stimulatory role of PKCalpha in extracellular regulated kinase 1/2 pathway in conjunctival goblet cell proliferation |
| Q49034731 | TNFR1-induced lethal inflammation is mediated by goblet and Paneth cell dysfunction |
| Q35721948 | The Endoplasmic Reticulum Stress Sensor IRE1α in Intestinal Epithelial Cells Is Essential for Protecting against Colitis. |
| Q37848454 | The host selects mucosal and luminal associations of coevolved gut microorganisms: a novel concept |
| Q26771122 | Therapeutic Potential to Modify the Mucus Barrier in Inflammatory Bowel Disease |
| Q91903810 | Therapeutic effect of gold nanoparticles on DSS-induced ulcerative colitis in mice with reference to interleukin-17 expression |
| Q35620108 | Vasoactive intestinal polypeptide promotes intestinal barrier homeostasis and protection against colitis in mice. |
| Q34972470 | iNOS-dependent increase in colonic mucus thickness in DSS-colitic rats |
| Q60550780 | β-Casein(94-123)-derived peptides differently modulate production of mucins in intestinal goblet cells |